RBI
VRTX icon

Raiffeisen Bank International’s Vertex Pharmaceuticals VRTX Stock Holding History

Raiffeisen Bank International’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$429K Hold
863
– – 0.01% 493
2026
Q1 		$385K Hold
863
– – 0.01% 465
2025
Q4 		$329K Hold
863
– – ﹤0.01% 450
2025
Q3 		$338K Buy
+863
New +$361K ﹤0.01% 439

Other funds holding VRTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swiss National Bank
Swiss National Bank Zurich, Switzerland $191B AUM 45.21% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Raiffeisen Bank International's VRTX Position: Q2 2026 in Review

Raiffeisen Bank International reduced its Vertex Pharmaceuticals (VRTX) stake by 4.2% in Q2 2026, selling an estimated $1.89M and leaving 97,170 shares worth $48.6M. The position accounts for 0.57% of the portfolio, ranked #42.

Raiffeisen Bank International first reported a position in VRTX in Q4 2024 and has held it in 7 quarters since. The position peaked at $64.8M in Q1 2025. 1,131 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Raiffeisen Bank International held 97,170 shares of Vertex Pharmaceuticals worth $48.6M as of Q2 2026.
  • Raiffeisen Bank International sold 4,265 Vertex Pharmaceuticals shares in Q2 2026, an estimated $1.89M.
  • Vertex Pharmaceuticals made up 0.57% of Raiffeisen Bank International's portfolio in Q2 2026, its #42 holding.
  • Raiffeisen Bank International first reported a position in Vertex Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • Raiffeisen Bank International's Vertex Pharmaceuticals position peaked at $64.8M in Q1 2025.
  • 1,131 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Raiffeisen Bank International's 13F filing for Q2 2026, filed 3 Aug 2026.